Asset Details
Do you wish to reserve the book?
Potentiation of ghrelin signaling attenuates cancer anorexia–cachexia and prolongs survival
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Potentiation of ghrelin signaling attenuates cancer anorexia–cachexia and prolongs survival
Do you wish to request the book?
Potentiation of ghrelin signaling attenuates cancer anorexia–cachexia and prolongs survival
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Potentiation of ghrelin signaling attenuates cancer anorexia–cachexia and prolongs survival
2011
Overview
Cancer anorexia–cachexia syndrome is characterized by decreased food intake, weight loss, muscle tissue wasting and psychological distress, and this syndrome is a major source of increased morbidity and mortality in cancer patients. This study aimed to clarify the gut–brain peptides involved in the pathogenesis of the syndrome and determine effective treatment for cancer anorexia–cachexia. We show that both ghrelin insufficiency and resistance were observed in tumor-bearing rats. Corticotropin-releasing factor (CRF) decreased the plasma level of acyl ghrelin, and its receptor antagonist, α-helical CRF, increased food intake of these rats. The serotonin 2c receptor (5-HT2cR) antagonist SB242084 decreased hypothalamic CRF level and improved anorexia, gastrointestinal (GI) dysmotility and body weight loss. The ghrelin receptor antagonist (D-Lys3)-GHRP-6 worsened anorexia and hastened death in tumor-bearing rats. Ghrelin attenuated anorexia–cachexia in the short term, but failed to prolong survival, as did SB242084 administration. In addition, the herbal medicine rikkunshito improved anorexia, GI dysmotility, muscle wasting, and anxiety-related behavior and prolonged survival in animals and patients with cancer. The appetite-stimulating effect of rikkunshito was blocked by (D-Lys3)-GHRP-6. Active components of rikkunshito, hesperidin and atractylodin, potentiated ghrelin secretion and receptor signaling, respectively, and atractylodin prolonged survival in tumor-bearing rats. Our study demonstrates that the integrated mechanism underlying cancer anorexia–cachexia involves lowered ghrelin signaling due to excessive hypothalamic interactions of 5-HT with CRF through the 5-HT2cR. Potentiation of ghrelin receptor signaling may be an attractive treatment for anorexia, muscle wasting and prolong survival in patients with cancer anorexia–cachexia.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ 692/420
/ Animals
/ Carcinoma, Hepatocellular - drug therapy
/ Carcinoma, Hepatocellular - etiology
/ Carcinoma, Hepatocellular - mortality
/ Corticotropin-Releasing Hormone - pharmacology
/ Corticotropin-Releasing Hormone - physiology
/ Drugs, Chinese Herbal - administration & dosage
/ Drugs, Chinese Herbal - pharmacology
/ Ghrelin - antagonists & inhibitors
/ Liver Neoplasms - drug therapy
/ Liver Neoplasms - metabolism
/ Male
/ Medicine
/ Original
/ Rats
/ Receptor, Serotonin, 5-HT2C - physiology
/ Receptors, Ghrelin - antagonists & inhibitors
/ Receptors, Ghrelin - physiology
/ Signal Transduction - drug effects
